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Abstract Timing of exposure to lifestyle factors that influ-
ence energy balance may differentially affect colorectal cancer
(CRC) risk and prognosis. Caloric restriction in youth and
short stature, as markers of early-life exposures, have shown
to decrease CRC risk, whereas large body size and low phys-
ical activity levels in adulthood are established risk factors for
CRC. Regarding prognosis, overweight, sarcopenia, and their
co-occurrence (sarcopenic obesity) may negatively influence
the health and quality of life of CRC survivors. There is
mechanistic support for disruption of the mammalian target
of rapamycin (mTOR) pathway as an underlying mechanism
possibly driving these associations, because mTOR integrates
signals from growth factors, nutrients, mutagens, and
hormones to induce cell proliferation, resistance to apoptosis,
and autophagy. However, epidemiologic evidence connecting
mTOR to energy-balance-related CRC throughout the life-
span is scarce. This perspective proposes how multidimen-
sional molecular epidemiologic studies can shed light on the
etiology and prognosis of energy-balance-related CRC.
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Introduction
During the course of the past century, epidemiological stud-
ies have been invaluable for advancing our knowledge about
modifiable risk factors for cancer. The influence of indica-
tors of energy imbalance, such as a high body mass index
and physical inactivity, on colorectal cancer (CRC) risk has
been some of the most convincing evidence to emerge from
such research [1]. Interestingly, increasing support also is
emerging for the importance of energy balance throughout
the lifespan for both cancer risk and prognosis [2••, 3].
A challenge of contemporary epidemiology is to deter-
mine the common molecular processes through which risk
factors operate [4]. There is now strong evidence to suggest
that the mammalian target of rapamycin (mTOR) plays a
critical role in human health and aging; a number of chronic
diseases are associated with disrupted mTOR signaling,
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including type 2 diabetes, obesity, metabolic syndrome, and
several types of cancer, including CRC [5, 6••, 7••].
The mechanisms of mTOR signaling are well described,
and animal studies have offered mechanistic insights support-
ing a role of mTOR in the association between energy balance
and cancer development. However, epidemiologic data re-
garding the connection between mTOR and CRC are scarce,
because few studies are large enough to consider small sub-
groups or do not yet have information on molecular and
genetic endpoints in tumors. Asmore and more studies around
the world are reaching the potential to gather this data, we
offer a perspective of how future research could proceed,
ideally by combining a number of research questions in one
study. Considering the association between energy balance
and CRC risk in a multidimensional fashion may not only
shed light on the etiology and prognosis of CRC, but also on
shared mechanisms underlying both CRC and other diseases.
This can be accomplished by accounting for multiple indica-
tors of energy exposure, including the timing of this exposure
throughout the lifespan, as well as molecular and genetic
characteristics of the tumor with respect to mTOR.
Lifestyle Factors Throughout the Lifespan that Influence
CRC Incidence and Prognosis
Energy balance refers to the relationship between energy
expenditure and energy intake. Energy imbalance resulting
from more energy intake than expenditure, as reflected
through overweight and obesity, is known to increase the
risk of CRC [1, 8–14]. In contrast, physical activity, which
can normalize this type of energy imbalance, has been
shown to decrease the risk of CRC [1, 15–21]. There is no
doubt that intra-abdominal (visceral) fat increases inflam-
matory responses and circulating estrogens, and decreases
insulin sensitivity [22]. As a proxy measure for visceral
adiposity, a high waist circumference has been associated
with CRC risk in epidemiologic studies, independent of
body mass index (BMI) [10, 23, 24]. Unique data from
periods of reduced food availability, such as the Dutch
Hunger Winter and World War 2 [25–32], support animal
studies suggesting that caloric restriction, which can induce
negative energy balance (less energy intake than expendi-
ture), is one of the most potent interventions for preventing
cancer [33–37]. Furthermore, timing of exposure to factors
relating to energy balance may be important for modifying
cancer risk.
Individuals who experienced caloric restriction in child-
hood and adolescence have a decreased risk of CRC later in
life compared to those who did not experience it [27, 29, 31,
32, 38]. In contrast, body fatness during childhood [39] and
adult-attained height, as a proxy measure for environmental
and nutritional exposures that occurred in utero and in early
childhood [40], are associated with an increased risk of CRC
and/or colorectal adenomas [1, 10, 23, 39, 41].
With the aging of the population, the number of individ-
uals living with a diagnosis of CRC (CRC survivors) is
increasing. However, the role of energy balance in deter-
mining the prognosis and quality of life of survivors, an
increasingly aging population, is still understudied [42]. The
favorable effect of physical activity on quality of life in
cancer survivors, including those with CRC [43], suggests
that energy balance is relevant for healthy survivorship in
this group as well. Although evidence is slowly accumulat-
ing for body fatness (usually assessed at or before diagnosis,
but rarely after treatment) to have detrimental effects on
survival, recurrence, and comorbidities in cancer survivors
[44••, 45], the influence of lean body mass, especially loss
of skeletal muscle mass (sarcopenia), on the health and
quality of life of CRC survivors remains underinvestigated.
Considerable variability in the body composition of CRC
survivors has been noted, especially with respect to cachexia
and sarcopenic obesity, i.e., muscle wasting without loss of
adipose tissue [46, 47]. Sarcopenia leads to muscle function
impairments, physical activity limitations, and restrictions in
societal participation. Besides tumor-related hypermetabo-
lism (increased resting energy expenditure, muscle protein
catabolism) and inflammation, the balanced process of mus-
cle protein turnover chiefly depends on nutrition and phys-
ical activity [48]. Both low-energy input (food intake,
mainly low-protein nutrition) and output (physical inactivi-
ty, mainly few strength-training-type activities) contribute to
progressive muscle wasting.
The mTOR Pathway in Energy-Related CRC
In a recent review, Chen identified multiple signaling path-
ways involved in obesity-associated cancer, and ultimately
postulated that mTOR activity could be the key to unlocking
the signal pathway changes that occur in the development of
such cancers [49]. mTOR is a highly evolutionary conserved
serine/threonine kinase that controls cell growth and metab-
olism in response to nutrients (e.g., amino acids), growth
factors (e.g., insulin, insulin-like growth factor (IGF)-1, acting
through phosphatidylinositol 3-kinase (PI3K)), cellular energy
(ATP acting through inhibition of adenosine monophosphate-
dependent protein kinase (AMPK)), and stress (e.g., hypoxia
and DNA damage) [7••, 50]. mTOR is at the interface between
growth and starvation. It positively regulates anabolic process-
es, such as transcription, protein synthesis, ribosome biogene-
sis, nutrient transport, and mitochondrial metabolism. At the
same time, mTOR negatively regulates catabolic processes,
such as mRNA degradation, ubiquitin-dependent proteolysis,
autophagy, and apoptosis. It also has been shown that sirtuin-1
(SIRT-1), which regulates energy efficiency during caloric
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restriction, may negatively regulate mTOR in response to
nutrients and cellular stress [51].
The PI3K-protein kinase B(Akt)-mTOR signaling pathway
includes several established proto-oncogenes (e.g. PI3K, v-akt
murine thymoma viral oncogene homolog 1 (AKT1)) and tumor
suppressor genes (e.g. phosphatase and tensin homolog (PTEN))
[7••, 52]. The PTEN protein antagonizes PI3K function and
negatively regulates Akt/mTOR activity [44••]. Epidemiological
data suggest that sporadic mutation or deregulation of PI3K, Akt
and PTEN are among the most prevalent alterations in human
cancer [7••, 54]. Recently, Gulhati et al. reported that activation
of PI3K-Akt is linked to growth and progression of CRC [55],
which supports their previous finding that mTOR kinase can
regulate CRC tumorgenesis [56].
A plausible mechanistic link between energy balance,
mTOR, and CRC development is insulin-like growth factor
1 (IGF-1) upstream from mTOR [57]. Evidence from animal
models supports the idea that reduction in circulating free
IGF-1 is associated with the anticancer effects of caloric
restriction [33, 58]. Epidemiological research has shown
that hyperinsulemia, which decreases IGF-1 binding protein
3 (IGFBP3) and consequently increases circulating IGF-1,
and diabetes both increase the risk of CRC [59–61]. Acti-
vation of mTOR has emerged as a critical event in rendering
insulin receptor substrate (IRS)-1 and IRS-2 unresponsive to
insulin and IGF-1 [62]. Therefore, proper regulation of the
PI3K-Akt-mTOR signaling pathway is critical for the pre-
vention of insulin resistance. Further evidence supporting
this link is that excess body fat is associated with both high
serum levels of IGF-1 and enhanced induction of the PI3K-
Akt-mTOR signaling pathway, whereas caloric restriction is
associated with reduced signaling as a result of decreased
circulating levels of IGF-1 [34, 63].
There are two functionally and structurally distinct com-
plexes which contain mTOR: mTOR complex 1 (mTORC1),
which is rapamycin sensitive, and mTORC2, which is rapa-
mycin insensitive. Although both are relevant for carcinogen-
esis, mTORC1 is thought to be influenced by energy balance,
specifically energy restriction [2••, 7••]. Molecular mediators
involved in muscle wasting likely include disruption of the
mTORC1 pathway. This energy balance-related pathway is a
crucial regulator of protein synthesis in response to energy
input (nutrient intake) and output (physical activity). Down-
regulated mTORC1 signaling results in reduced protein trans-
lation and promotes protein breakdown via autophagy [7••,
64]. Decreased levels of circulating amino acids, glucose,
insulin, and IGF-1 reduce mTORC1 signaling. Research on
sarcopenia underscores that probably both essential amino
acid availability, especially leucine, and resistance exercise
counteract sarcopenia through acute regulation of mTORC1
signaling [7••, 48, 65–67]. It also is noteworthy that metfor-
min, the initial glucose lowering therapy for type 2 diabetic
patients, has been associated with a significantly lower risk of
CRC in type 2 diabetic patients in a recent meta-analysis [68].
The mechanism of action of metformin is believed to be
through activation of AMPK and hence inhibition of
mTORC1 signaling. Tissue specificity of mTORC1 signaling
has yet to be determined. It is plausible that epigenetic
changes, such as methylated IGFBP genes in CRC, may
disrupt mTORC1 signaling in CRC cells.
Toward a Multidimensional Molecular
Epidemiologic Approach
We propose a multidimensional molecular epidemiologic
approach to further unravel the role of the mTOR signaling
pathway in energy-balance-related CRC etiology and prog-
nosis throughout life (Fig. 1). Ideally, simultaneous investi-
gation of a range of exposures and their joint effects, the
timing of exposures, and diverse molecular biomarkers of
the mTOR pathway is considered in future studies.
Consider a Range of Exposures and Their Joint Effects
In general, it is difficult to account accurately for energy
balance in epidemiological studies, because energy balance is
maintained by a complex system involving multiple pathways
and is dependent on genetic factors. The variables used in
epidemiological studies, such as BMI, waist circumference,
caloric intake, and physical activity status, are not sufficient
on their own to describe overall energy balance status [58].
Considering joint effects can help paint a more comprehensive
picture than considering single variables in isolation. Both BMI
and waist circumference have been reported to show interac-
tions with physical activity levels in relation to CRC [10, 69,
70]. Such joint effects, which have not yet been investigated
systematically, can reveal associations that may remain masked
when focusing on just one aspect of energy balance.
In addition, investigating both ends of the exposure spec-
tra throughout the lifespan can reinforce our knowledge of
underlying pathways. As reviewed earlier, both caloric ex-
cess and caloric restriction, as well as sarcopenic obesity in
CRC survivors, are associated with either cancer risk or
prognosis, respectively, in part through their influence on
mTOR signaling. Therefore, with respect to untangling the
role of mTOR in the association between energy balance
and CRC, and in terms of creating prevention strategies, it is
most informative to consider joint associations between
exposure variables within studies if possible or otherwise
consider literature from different exposure spectra.
Consider the Timing of Exposures
Studying the timing of exposure can shed valuable insights
into cancer etiology. Epidemiological studies have shown
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that timing of exposure, both in terms of the life phase
during which exposure occurs [27, 29, 31, 32, 38, 39], and
in terms of changes in exposure over time [71], may be
important for modulating CRC risk. Examples from animal
models of other cancer types support this idea with respect
to mTOR signaling [72, 73].
Childhood obesity is now a major health concern, but the
long-term consequences of being obese during this critical
phase of growth and development remain largely undeter-
mined. To our knowledge, no study has investigated the role
of indicators of energy balance early in life and the effect of
mTOR signaling in cancer later in life. However, evidence
from a rat study investigating radiation exposure early in life
supports that early life environmental exposure may have
mechanistic implications for mTOR. In this study, Kokubo
et al. [72] assessed the risk of renal cell carcinoma in rats
irradiated at various time points in the gestational and post-
natal period. At 27 weeks of age, kidneys were examined for
proliferative lesions. Compared with unirradiated controls,
adenoma and adenocarcinoma development were evident in
perinatally irradiated kidneys. Furthermore, these malignant
changes were associated with mTOR activation in tumors,
suggesting that early life environmental exposure has impli-
cations for mTOR signaling.
With respect to changes in exposure over time, a recent
study by De Angel et al. [73] investigated the impact of
weight normalization in ovariectomized female mice on
breast cancer development. Mice were fed a control diet, a
calorie reduced (CR) diet, or an obesity inducing (DIO) diet.
At 17 weeks, the mice on the obesity-inducing diet were
switched to a control diet, resulting in obese mice decreas-
ing to a similar weight to the controls by week 20. Relative
to controls, CR mice had decreased, and DIO mice had
increased serum IGF-1 and phosphorylation of Akt/mTOR
pathway components. Of relevance to the point at hand is
that weight normalization in obese mice did not immediately
reverse tumor progression or Akt/mTOR activation. If rep-
licated in humans, this finding could have implications for
prevention strategies.
Consider Diverse Molecular Biomarkers
Biomarkers of Exposure
Assessing exposure in large-scale, prospective, epidemio-
logic studies is a major challenge and assessing early life-
time exposures is even more challenging. Biomarkers relat-
ed to altered energy balance during different phases of life
could lend support to observed associations between indi-
cators of energy balance and CRC in epidemiological stud-
ies. Multiple cancer risk factors have been identified in
relation to obesity, including increased blood levels of insu-
lin, IGF1, estrogen, proinflammatory cytokines, adipokines,
and other inflammatory markers [4, 49, 60, 61, 74–76]. As
reviewed by Chen [49], animal studies have shown that such
factors exert their effects by activating multiple signaling
Fig. 1 A multidimensional molecular epidemiologic approach to studying the role of mTOR and energy balance throughout the lifespan in
colorectal cancer etiology and prognosis
22 Curr Nutr Rep (2013) 2:19–26
pathways, including PI3K-Akt and IGF signaling pathways,
which in turn lead to the activation of mTOR.
Exciting developments and opportunities should be moni-
tored for potential application in epidemiologic studies. For
example, gut microbial enterotypes have recently been associ-
ated with long-term dietary patterns, specifically protein and
animal fat (Bacteroides) versus carbohydrates (Prevotella)
[74]. In a study comparing the fecal microbiota of children
living in Europe and rural Burkina Faso, where the diet is high
in fiber content, significant differences in gut microbiota be-
tween the two groups were observed, for example, with an
abundance of Prevotella bacteria in the children from Africa
[75]. These studies are just emerging and need to be replicated,
but the composition of gut microbiota may be an interesting
future tool to fingerprint early-life and long-term exposures,
including the diet, and their role in pathways, such as the
mTOR pathway to CRC cancer.
Biomarkers of Outcome
One of the most exciting developments in modern epidemiol-
ogy is the emergence of the field of molecular pathological
epidemiology. As Ogino et al. describe, a strength of this type
of research is that germ line genetic variants and molecular
alterations in the tumor can be studied simultaneously, and as
such, the specificity of the relationship between genetic var-
iants and tumor molecular alterations can provide additional
evidence to support a causal effect of the putative cancer
susceptibility allele [76]. In addition, the molecular signatures
of tumors can be viewed as fingerprints of prior internal and
external exposures, because the timing of molecular events in
carcinogenesis are known to differ, with epigenetic changes
occurring relatively early in carcinogenesis. In the Netherlands
Cohort Study on diet and cancer, early-life exposure to energy
restriction was inversely associated with CRC risk according
to the degree of promoter hypermethylation in a number of
cancer-related genes [38]. This result suggests that exposure to
severe malnutrition during youth can protect from persistent
epigenetic changes that later influence CRC development.
Biomarkers of Susceptibility
Genetic variants can be viewed as time-independent bio-
markers of pathway involvement [77]. Selecting genetic
variants from pathways related to mTOR signaling and
investigating their interaction with determinants of energy
balance in relation to CRC is thereby another promising
avenue for molecular epidemiologic research in this area.
In 2009, Slattery et al. proposed the “convergence of hor-
mones, inflammation, and energy-related factors” (CHIEF)
pathway, to provide a mechanistic explanation for the conver-
gent effects of inflammation, hormones, and energy-related
factors, such as obesity, physical activity, and energy intake on
colorectal carcinogenesis [4]. Supported by molecular and
epidemiological evidence, there are two major arms of the
pathway, one of which contains mTOR. Using data from the
Northern California Kaiser Permanente Medical Care Pro-
gram (KPMCP) and the Twin Cities Metropolitan area of
Minnesota, Slattery et al. investigated genetic variation in
the CHIEF pathway and showed that variation in mTOR
altered the risk of CRC, even after adjustment for multiple
comparisons [78]. Intriguingly, when molecular tumor
markers were taken into account, the strongest associations
for mTOR were observed for tumors characterized by micro-
satellite instability (MSI). This suggests that through the
CHIEF pathway, mTORmay influence risk through epigenet-
ic changes, and shows the importance of considering both the
genetic and molecular characteristics of the tumor.
The benefit of studying gene-environment interactions can
be seen in a recent case-control study by Lin et al. [70], in
which the association between energy balance and risk of
bladder cancer was investigated in 803 cases and matched
controls by assessing the joint effects of genetic variants in
PI3K-Akt-mTOR pathway genes with indicators of energy
balance. Although several, large, population-based studies
have reported genetic variability of the mTOR pathway with
respect to cancer risk [52, 78, 79], to our knowledge, the study
of Lin et al. is the only study to date to consider energy balance
additionally in this equation. To explore how unfavorable
genotypes in the mTOR pathway may modify the association
between energy balance and cancer risk, the authors created a
sum of unfavorable genotypes to conduct a stratified analysis
(0–4 unfavorable genotypes, 5–6 unfavorable genotypes, and
≥7 unfavorable genotypes). Those subjects with the worst
“energy balance” category (high caloric intake, low physical
activity, high number of unfavorable genotypes) had a signif-
icantly higher risk of bladder cancer compared with those
individuals with the most favorable energy balance category
(low caloric intake, intensive physical activity, low number of
unfavorable genotypes). Intriguingly, this effect was stronger
thanwhen caloric intake and physical activity were considered
independently from each other.
Conclusions
Although with small sample sizes it may be a challenge for
individual cohorts to combine our suggested considerations
into one study, there is emerging potential to pool data from
multiple studies utilizing a molecular pathological epidemi-
ology approach to research [80, 81]. Furthermore, besides
increased statistical power when data from multiple studies
are appropriately combined, the findings from such pooled
cohorts will have increased generalizability and external va-
lidity. Such collaboration and cooperation will serve to ad-
vance population science and public health [81]. It also is
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intriguing to speculate about how future studies could simul-
taneously focus on multiple diseases that are interlinked
through the mTOR signaling pathway and shared risk factors.
For example, energy imbalance is a risk factor for several
types of cancer in addition to CRC, which also have been
shown to demonstrate impaired mTOR signaling. These in-
clude breast cancer [34, 73, 82], bladder cancer [70, 79], and
renal cell carcinoma [53]. One may hypothesize that despite
the different tumor types, a similar underlyingmechanism is at
play. Therefore, to find out howmolecular and genetic aspects
of mTOR signaling pathway genes modify the association
between energy balance and cancer, it may be informative
and statistically more powerful to consider cancer as a single
endpoint comprised of a number of specific cancers that may
share etiology, such as obesity-related cancers. Furthermore,
as noted earlier, dysregulated mTOR signaling is associated
with several diseases that are associated with CRC, such as
metabolic syndrome and type 2 diabetes [5, 6••, 7••]. A truly
multidimensional approach, and one that would shed valuable
insight on etiology, would be to simultaneously consider these
related diseases so that the pathway to disease is being inves-
tigated rather than individual disease endpoints.
In conclusion, defects in mTOR signaling may be the key to
unlocking the reported associations between overweight, obe-
sity, caloric restriction throughout life, and CRC. We have
presented a perspective of how future epidemiological studies
could proceed to glean the most mechanistic information about
such biological pathways. Considering genetic and molecular
aspects of the mTOR signaling pathway in conjunction with
indicators of energy balance at different periods of life will
result in a better understanding of CRC etiology and prognosis,
which is necessary for fine tuning prevention strategies.
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